Licensed medical cannabis wholesaler Sativite has announced an exclusive partnership with Jamaica Medical Cannabis Corporation (JMCC) to act as the firm’s distributor in Australia, New Zealand and other Asia-Pac countries where medical use is legal.

Under the agreement, Sativite will sell and distribute JMCC’s Jamaican-grown dried
cannabis flower, which will be GMP-certified by Q2 with organic certification following
in late-2021. Sativite will also distribute JMCC Scientific’s products later this year.

Sativite CEO Mike Cleary

Sativite CEO Mike Cleary said: “One of the reasons we were so keen to work with JMCC is that we can offer high-quality and differentiated medical products at relatively affordable prices, thanks to JMCC’s decision to grow a pharma-grade product as naturally as possible in an ideal climate like Jamaica’s.”

He added: “There’s nothing like them in Australia yet, in terms of bioavailability, dosage accuracy and ease-of-use. We believe doctors, pharmacists and patients will
be as excited by them as we are.”

Sativite has established greenfield operations in New South Wales and Queensland.

Prior to launching Cannabiz, Martin was co-founder and CEO of Asia-Pac’s leading B2B media and marketing information brand Mumbrella, overseeing its sale to Diversified Communications in 2017. A journalist...